Here are what the editors at HealthDay consider to be the most important developments in Critical Care for September 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
COVID-19 Tests for Return to Work May Delay Health Workers
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Health care workers (HCWs) diagnosed with COVID-19 can have a prolonged recovery of viral RNA, which can delay return to work (RTW), according to research published online Aug. 26 in Infection Control & Hospital Epidemiology.
Abstract/Full Text (subscription or payment may be required)
COVID-19-Related Hospital Death Up With Psychiatric Diagnosis
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Patients with any prior psychiatric diagnosis have an increased risk for COVID-19-related hospital death, according to a research letter published online Sept. 30 in JAMA Network Open.
Recent Increase Seen in COVID-19 Incidence Among 18- to 22-Year-Olds
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — During Aug. 2 to Sept. 5, 2020, there was a 55.1 percent increase in the weekly incidence of COVID-19 nationally among young adults aged 18 to 22 years, according to research published in the Sept. 29 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Current Trends in COVID-19 Reported for U.S. Youth
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — The incidence of COVID-19 was higher in adolescents than among children during May to September 2020, according to research published in the Sept. 28 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
No Race Difference Found in COVID-19 Mortality Rates at Same Medical Center
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — For admitted COVID-19 patients presenting to the same urban medical center, risk-adjusted outcomes were no worse for non-Hispanic Black and Hispanic patients versus non-Hispanic White patients, according to a study published online Sept. 25 in JAMA Network Open.
Hospital Admissions Not Related to COVID-19 Fell in Early 2020
WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Non-COVID-19 hospital admissions decreased considerably with the onset of COVID-19, with declines generally similar across patient demographic subgroups from February to April 2020, according to a report published online Sept. 24 in Health Affairs.
U.S. Government to Ship Millions of Rapid COVID-19 Tests This Week
TUESDAY, Sept. 29, 2020 (HealthDay News) — The U.S. government will start distributing millions of rapid COVID-19 tests to states this week with the goal of reopening schools.
Global Death Toll From COVID-19 Passes 1 Million
TUESDAY, Sept. 29, 2020 (HealthDay News) — The global COVID-19 pandemic reached a grim new milestone on Tuesday: 1 million dead.
Women With AMI-Cardiogenic Shock Treated Less Aggressively
TUESDAY, Sept. 29, 2020 (HealthDay News) — Among young adults with acute myocardial infarction-cardiogenic shock (AMI-CS), women are treated less aggressively and have higher in-hospital mortality than men, according to a study published online Sept. 29 in Circulation: Heart Failure.
Abstract/Full Text (subscription or payment may be required)
Outcomes of In-Hospital Cardiac Arrest Poor in COVID-19 Patients
MONDAY, Sept. 28, 2020 (HealthDay News) — None of 54 patients hospitalized with COVID-19 with in-hospital cardiac arrest who underwent cardiopulmonary resuscitation (CPR) survived to discharge, according to a research letter published online Sept. 28 in JAMA Internal Medicine.
Editorial (subscription or payment may be required)
Brain-Eating Amoeba Found in Tap Water of Lake Jackson, Texas
MONDAY, Sept. 28, 2020 (HealthDay News) — The presence of a brain-eating amoeba in its drinking water has led the city of Lake Jackson, Texas, to issue a “do not use water order” and request an emergency declaration from the state.
Private Health Plans Pay Hospitals 247 Percent of Medicare
MONDAY, Sept. 28, 2020 (HealthDay News) — During 2018, prices paid to hospitals by privately insured patients averaged 247 percent of what Medicare would have paid, according to a study from the RAND Corporation.
Infants of COVID-19-Infected Mothers Doing Well in Short Term
MONDAY, Sept. 28, 2020 (HealthDay News) — Infants born to mothers testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not have a higher frequency of adverse outcomes than those born to mothers testing negative, according to a brief report published online Sept. 18 in Clinical Infectious Diseases.
Abstract/Full Text (subscription or payment may be required)
Clinical Severity Lower With Vitamin D Sufficiency in COVID-19
MONDAY, Sept. 28, 2020 (HealthDay News) — Vitamin D sufficiency is associated with reduced clinical severity, inpatient mortality, and serum levels of C-reactive protein (CRP) among patients infected with COVID-19, according to a study published online Sept. 25 in PLOS ONE.
<10 Percent of U.S. Population Has Antibodies to SARS-CoV-2
MONDAY, Sept. 28, 2020 (HealthDay News) — Fewer than 10 percent of the U.S. adult population formed antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the first wave of the pandemic, according to a study published online Sept. 25 in The Lancet.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 21 to 25, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Median Age of COVID-19 Cases Declined in May to August in U.S.
FRIDAY, Sept. 25, 2020 (HealthDay News) — From May to August 2020, there was a decrease in the median age of COVID-19 cases in the United States, according to research published in the Sept. 23 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
THURSDAY, Sept. 24, 2020 (HealthDay News) — A Chinese pharmaceutical company claims its COVID-19 vaccine should available by early next year for distribution in the United States and other countries.
Acute Kidney Injury Ups Risk for Death in COVID-19 Patients
THURSDAY, Sept. 24, 2020 (HealthDay News) — Acute kidney injury (AKI) in hospitalized patients with COVID-19 is associated with a significantly higher risk for in-hospital death, according to a study published online Sept. 19 in the American Journal of Kidney Diseases.
As Flu Season Approaches, Clinicians Brace for Potential ‘Twindemic’
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Flu shots may be more important than ever this year, as COVID-19 presents new challenges for clinicians and communities this flu season. HD Live! spoke with Nadia Eltaki, M.D., director of clinical operations at Sibley Memorial Hospital in Washington, D.C., to discuss how clinicians can potentially lessen the potential for an overlapping superinfection, or “twindemic.”
U.S. COVID-19 Death Toll Hits 200,000 as Cases Climb in 22 States
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The U.S. COVID-19 death toll reached the tragic milestone of 200,000 on Tuesday, with at least 22 states now reporting a rise in new cases. Just last Monday, only nine states were reporting increases in new COVID-19 cases, CNN reported. For the most part, the case spikes are showing up in the country’s heartland and the Midwest.
Stricter Vaccine Approval Rules Coming From FDA
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Stricter guidelines for emergency use authorization of a vaccine against the new coronavirus could soon be issued by the U.S. Food and Drug Administration.
J&J COVID-19 Vaccine Begins Final Stage of Clinical Trials
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — The final stage of clinical trials for Johnson & Johnson’s COVID-19 vaccine have started, the company announced Tuesday.
SARS-CoV-2 Mortality Mainly Linked to Older Age, Comorbidity
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — For U.S. veterans with COVID-19, mortality is mainly associated with older age, male sex, and comorbidity, according to a study published online Sept. 23 in JAMA Network Open.
Red Blood Cell Distribution Width, Mortality Tied in COVID-19
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — For patients with COVID-19, elevated red blood cell distribution width (RDW) is associated with increased mortality risk, according to a study published online Sept. 23 in JAMA Network Open.
Most People With SARS-CoV-2 Do Not Remain Asymptomatic
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Most people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not remain asymptomatic, and the secondary attack rate is lower among contacts of people with asymptomatic infection, according to a review published online Sept. 22 in PLOS Medicine.
AKI Occurs in 7 Percent of Those Hospitalized With COVID-19
TUESDAY, Sept. 22, 2020 (HealthDay News) — Acute kidney injury (AKI) occurs in 7 percent of patients hospitalized with COVID-19 and is associated with increased in-hospital mortality, according to a study published online Sept. 22 in the Clinical Journal of the American Society of Nephrology.
Rates of COVID-19 Infection Higher in Blacks, Hispanics
TUESDAY, Sept. 22, 2020 (HealthDay News) — Black and Hispanic individuals are experiencing an excess burden of severe acute respiratory syndrome coronavirus 2 infection, according to a study published online Sept. 22 in PLOS Medicine.
CDC Removes New COVID-19 Guidelines Just Days After Posting Them
MONDAY, Sept. 21, 2020 (HealthDay News) — New U.S. Centers for Disease Control and Prevention website guidelines suggesting that the new coronavirus can be transmitted by tiny droplets over a distance greater than six feet and that indoor ventilation is crucial to prevent its spread were removed from the agency’s website late Monday morning.
AstraZeneca Releases COVID-19 Vaccine Trial Plans
MONDAY, Sept. 21, 2020 (HealthDay News) — AstraZeneca is the latest drug company to release details about human tests of its COVID-19 vaccine in response to public demand for such information. Americans have increasing doubts about a COVID-19 vaccine, and experts are worried that an unproven or unsafe vaccine may be released prematurely due to pressure from President Donald Trump, The New York Times reported.
COVID-19 Death Toll Nears 200,000 in the United States
MONDAY, Sept. 21, 2020 (HealthDay News) — As the U.S. COVID-19 case count neared 200,000 on Monday, public health experts debated whether the spread of the virus will continue to slow or a new surge will come, as cold weather returns to much of the country.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 14 to 18, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Details Emerge on Unexplained Illness in AstraZeneca COVID-19 Vaccine Trial
FRIDAY, Sept. 18, 2020 (HealthDay News) — New details surfaced on Thursday on an unexplained neurological condition that struck a volunteer who was participating in AstraZeneca’s COVID-19 vaccine trial.
CDC: Adult Obesity Increasing, Tied to Worse COVID-19 Outcomes
FRIDAY, Sept. 18, 2020 (HealthDay News) — Adult obesity is increasing, with considerable racial and ethnic disparities, according to new data from the U.S. Centers for Disease Control and Prevention.
Drug May Reduce Need for Ventilators in COVID-19 Patients
FRIDAY, Sept. 18, 2020 (HealthDay News) — An inflammation-fighting medicine was associated with reduced use of ventilators among COVID-19 patients, according to a study that included mainly Hispanics and Blacks.
More Than Half of Pregnant Women With COVID-19 Asymptomatic
FRIDAY, Sept. 18, 2020 (HealthDay News) — More than half of hospitalized pregnant women with COVID-19 are asymptomatic at admission, while pregnant women hospitalized for COVID-19-related illness have a higher prevalence of prepregnancy obesity and gestational diabetes, according to two studies published in the Sept. 16 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Abstract/Full Text – Panagiotakopoulos
Lower Proportion of Inpatients With COVID-19 Wear Glasses
FRIDAY, Sept. 18, 2020 (HealthDay News) — The proportion of inpatients with COVID-19 who wear eyeglasses for extended daily periods is lower than in the general population, according to a study published online Sept. 16 in JAMA Ophthalmology.
Flu Activity Low in Southern Hemisphere in June to August 2020
THURSDAY, Sept. 17, 2020 (HealthDay News) — There was very low influenza activity during June to August 2020 in the Southern Hemisphere, according to research published in the Sept. 18 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Moderna May Know by November Whether COVID-19 Vaccine Is Effective
THURSDAY, Sept. 17, 2020 (HealthDay News) — Moderna says it should know by sometime in November whether its COVID-19 vaccine is effective, its CEO said Thursday.
COVID-19 Vaccine Distribution Would Begin Within 24 Hours After Approval
THURSDAY, Sept. 17, 2020 (HealthDay News) — Distribution of a COVID-19 vaccine in the United States would begin within 24 hours of its approval or emergency use authorization, and the plan is that no American will have to “pay a single dime” out of their own pocket for the vaccine, federal officials said Thursday.
Substance Use Disorder Linked to Increased Risk for COVID-19
THURSDAY, Sept. 17, 2020 (HealthDay News) — Substance use disorder (SUD) is associated with a higher risk for COVID-19 than that seen in the general population, as well as worse outcomes, according to a study published online Sept. 14 in Molecular Psychiatry.
Survey: About Seven in 10 Adults Interested in COVID-19 Vaccine
THURSDAY, Sept. 17, 2020 (HealthDay News) — Nearly seven in 10 U.S. adults are “definitely” or “probably” willing to get a COVID-19 vaccine, according to research published online Aug. 20 in Vaccine.
Hydrocortisone Early After Septic Shock Onset May Aid Outcomes
THURSDAY, Sept. 17, 2020 (HealthDay News) — For patients with vasopressor-dependent septic shock, early hydrocortisone use is associated with improved outcomes, according to a study published online Sept. 2 in SHOCK.
Abstract/Full Text (subscription or payment may be required)
Characteristics ID’d for Under 21s With SARS-CoV-2-Linked Deaths
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — Of those aged younger than 21 years with deaths associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), most are aged 10 to 20 years, and 75 percent of deaths occur in those with an underlying medical condition, according to research published in the Sept. 15 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Vaccine Campaign Would Take Six to Nine Months to Curb COVID-19
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — When a safe and effective vaccine against COVID-19 becomes available, it is likely to take six to nine months for enough Americans to get vaccinated to have a significant impact on the pandemic, U.S. Centers for Disease Control and Prevention Director Robert Redfield, M.D., said Wednesday.
New Drug Shows Promise in Preventing Severe COVID-19
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — A single infusion of an experimental drug dramatically lowers levels of coronavirus in the bodies of newly infected patients and cuts their chances of hospitalization, the drug’s maker reported Wednesday.
Portable Low-Field MRI Allows Brain Imaging in ICU Patients
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — Portable, low-field magnetic resonance imaging (MRI) is feasible for obtaining neuroimaging in intensive care unit (ICU) patients, according to a study published online Sept. 8 in JAMA Neurology.
Many Doctors Misinformed About Nicotine’s Risks
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — Most doctors hold misperceptions about the risks of nicotine, according to research published online Sept. 1 in the Journal of General Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Poll: Most Americans Do Not Trust Trump’s COVID-19 Vaccine Comments
TUESDAY, Sept. 15, 2020 (HealthDay News) — In a sign that Americans are becoming more wary about the safety of a COVID-19 vaccine, a new poll shows a majority of adults do not trust what President Donald Trump has said on vaccine development.
Factor V Activity Significantly Increased in Severe COVID-19
TUESDAY, Sept. 15, 2020 (HealthDay News) — Factor V activity is significantly increased in patients with severe COVID-19, according to a study published online Aug. 24 in the American Journal of Hematology.
Abstract/Full Text (subscription or payment may be required)
Canada Reports No New COVID-19 Deaths for First Time in Six Months
MONDAY, Sept. 14, 2020 (HealthDay News) — For the first time in six months, Canada on Friday reported no new COVID-19 deaths.
AstraZeneca COVID-19 Vaccine Trial Restarts
MONDAY, Sept. 14, 2020 (HealthDay News) — Oxford University has announced that final-stage testing of a COVID-19 vaccine it is developing with drug maker AstraZeneca will restart following a pause last week after a serious side effect showed up in a volunteer.
Effectiveness of Inhaled COVID-19 Vaccines to Be Studied
MONDAY, Sept. 14, 2020 (HealthDay News) — A study to assess the effectiveness of two experimental COVID-19 vaccines when they are inhaled, rather than injected, has been announced by researchers.
Baricitinib May Shorten Recovery Time in Hospitalized COVID-19 Patients
MONDAY, Sept. 14, 2020 (HealthDay News) — Using an anti-inflammatory medicine along with the antiviral drug remdesivir appears to shorten COVID-19 patients’ recovery time, according to drug company Eli Lilly.
NIH Launches Clinical Trials of Antithrombotics for COVID-19
MONDAY, Sept. 14, 2020 (HealthDay News) — Two of three planned adaptive phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19 have launched, according to an announcement by the National Institutes of Health (NIH).
24.4 Percent of U.K. Health Care Workers Positive for SARS-CoV-2
MONDAY, Sept. 14, 2020 (HealthDay News) — The overall prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies is 24.4 percent in a cohort of asymptomatic health care workers, according to a study published online Sept. 11 in Thorax.
Florida Teen Dies From Brain-Eating Amoeba
FRIDAY, Sept. 11, 2020 (HealthDay News) — The parents of a 13-year-old boy in Florida who died from brain-eating amoeba want to warn others about the risk of the waterborne infection.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Sept. 7 to 11, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Pneumothorax Reported as Complication of COVID-19
FRIDAY, Sept. 11, 2020 (HealthDay News) — Pneumothorax is being reported as a complication of COVID-19, and has higher incidence among men and lower survival among older patients, according to a study published online Sept. 9 in the European Respiratory Journal.
Widespread Avoidance of Medical Care Found Due to COVID-19 Concerns
THURSDAY, Sept. 10, 2020 (HealthDay News) — There was widespread reporting of avoidance of medical care due to COVID-19-related concerns in June 2020, according to research published in the Sept. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
CDC: Nearly 800 U.S. Children Have Developed COVID-19-Related Condition
THURSDAY, Sept. 10, 2020 (HealthDay News) — There have been 792 confirmed cases in the United States of a rare condition in children that is linked to COVID-19, the U.S. Centers for Disease Control and Prevention said Wednesday.
Considerable Adverse Outcomes Reported for Young Adults With COVID-19
THURSDAY, Sept. 10, 2020 (HealthDay News) — Young adults hospitalized with COVID-19 have substantial rates of adverse outcomes, according to a research letter published online Sept. 9 in JAMA Internal Medicine.
Nosocomial COVID-19 Rare During Height of Pandemic
THURSDAY, Sept. 10, 2020 (HealthDay News) — During the height of the pandemic, the incidence of nosocomial COVID-19 was rare, according to a study published online Sept. 9 in JAMA Network Open.
Time to Decannulation Shorter if Based on Suctioning Frequency
THURSDAY, Sept. 10, 2020 (HealthDay News) — A protocol based on suctioning frequency plus continuous high-flow oxygen therapy results in a shorter time to decannulation among conscious, critically ill patients with a tracheostomy tube, according to a study published in the Sept. 10 issue of the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
New COVID-19 Test Provides Results in 15 Minutes
WEDNESDAY, Sept. 9, 2020 (HealthDay News) — A new portable COVID-19 test that can provide results within 15 minutes and process up to 30 samples an hour could be available by the end of the year, according to medical diagnostics company Qiagen.
Clinical Trial of AstraZeneca COVID-19 Vaccine Paused After Illness
WEDNESDAY, Sept. 9, 2020 (HealthDay News) — A “potentially unexplained” illness in a participant has led AstraZeneca to halt a late-stage clinical trial of its COVID-19 vaccine.
More Than Half a Million U.S. Children Already Infected With COVID-19
WEDNESDAY, Sept. 9, 2020 (HealthDay News) — More than 500,000 U.S. children had been diagnosed with COVID-19 as of early September, with a sizable uptick seen in recent weeks, a new report reveals.
Drug Companies Say Ethical, Scientific Standards Will Be Followed in Making COVID-19 Vaccines
WEDNESDAY, Sept. 9, 2020 (HealthDay News) — The highest ethical and scientific standards will be followed in testing and manufacturing vaccines against the new coronavirus, the top executives of nine U.S. and European drug companies promise.
Child Hospital, ICU Admission Rates Similar for COVID-19, Flu
WEDNESDAY, Sept. 9, 2020 (HealthDay News) — Among children with COVID-19 or seasonal influenza, there are no differences in hospitalization rates, intensive care unit (ICU) admission rates, or mechanical ventilator use, but children with COVID-19 have more clinical symptoms, according to a study published online Sept. 8 in JAMA Network Open.
Median of 36 Days Found From COVID-19 Symptom Onset to Viral Clearance
WEDNESDAY, Sept. 9, 2020 (HealthDay News) — The median time from COVID-19 symptom onset to viral clearance is 36 days, according to a study published online Sept. 2 in BMJ Open.
States Should Prepare for COVID-19 Vaccine by Nov. 1
TUESDAY, Sept. 8, 2020 (HealthDay News) — Even though it is not likely to happen, states should be prepared to distribute a COVID-19 vaccine by Nov. 1, the U.S. Surgeon General said Sunday.
As Tough COVID-19 Summer Ends, Experts Warn of Tougher Fall, Winter
TUESDAY, Sept. 8, 2020 (HealthDay News) — In a sobering illustration of the toll the COVID-19 pandemic took this summer, tallies now show the number of Americans who have died of the infection jumped from just under 100,000 to more than 186,000 between Memorial Day and Labor Day, while cases more than quadrupled to over 6.2 million.
Four Studies Indicate Benefits of Steroids for COVID-19
TUESDAY, Sept. 8, 2020 (HealthDay News) — Steroids can improve survival in patients with COVID-19, according to three randomized trials and a meta-analysis published online Sept. 2 in the Journal of the American Medical Association.
AKI Common in Hospitalized Patients With COVID-19
TUESDAY, Sept. 8, 2020 (HealthDay News) — Acute kidney injury (AKI) is common in hospitalized patients with COVID-19 and is associated with increased in-hospital mortality, according to a study published online Sept. 3 in the Journal of the American Society of Nephrology.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Aug. 31 to Sept. 4, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Chief of U.S. Vaccine Initiative Says October Timeline ‘Extremely Unlikely’
FRIDAY, Sept. 4, 2020 (HealthDay News) — The chief adviser for the White House vaccine program said Thursday it was “extremely unlikely, but not impossible” that a COVID-19 vaccine could be available by the end of October.
Likely Deficient Vitamin D Status Linked to COVID-19 Risk
FRIDAY, Sept. 4, 2020 (HealthDay News) — Likely deficient vitamin D status is associated with an increased risk for COVID-19, according to a study published online Sept. 3 in JAMA Network Open.
COVID-19 During Pregnancy May Pose Risks for Mother, Baby
FRIDAY, Sept. 4, 2020 (HealthDay News) — Pregnant women with COVID-19 are less likely to report symptoms but are more likely to require intensive care unit admission compared with nonpregnant women of reproductive age, according to a systematic review and meta-analysis published online Sept. 1 in The BMJ.
CDC Refutes Social Media Rumors That COVID-19 Death Data Are Inaccurate
THURSDAY, Sept. 3, 2020 (HealthDay News) — Rumors suggesting that COVID-19 deaths in the United States are much lower than reported are due to people misinterpreting standard death certificate language, a U.S. Centers for Disease Control and Prevention official says.
John Wagner No Longer Heading FDA Office of External Affairs
THURSDAY, Sept. 3, 2020 (HealthDay News) — For the second time in days, a Trump appointee to the U.S. Food and Drug Administration has been let go.
Poll: Americans Now More Likely to Get COVID-19 Vaccine
THURSDAY, Sept. 3, 2020 (HealthDay News) — Just over 54 percent of Americans now say they would get a COVID-19 vaccine in the first 12 months after it is introduced, a significant increase from 42 percent in July, a new WebMD poll finds.
U.S. Will Not Join International COVID-19 Vaccine Effort
WEDNESDAY, Sept. 2, 2020 (HealthDay News) — The United States will not join an international effort to create and distribute a COVID-19 vaccine, the Trump administration said Tuesday.
CDC Alerts Nation to Prepare for COVID-19 Vaccine by Early November
WEDNESDAY, Sept. 2, 2020 (HealthDay News) — The U.S. Centers for Disease Control and Prevention is telling the nation to prepare for distribution of a COVID-19 vaccine this fall.
No Proof Convalescent Plasma Effective Against COVID-19
WEDNESDAY, Sept. 2, 2020 (HealthDay News) — There is no evidence to support the use of convalescent plasma to treat COVID-19 patients, and doctors should not consider it a standard of care until more research is completed, a U.S. National Institutes of Health expert panel said Tuesday.
California Chicken Plant Closes After 8 Employees Die From COVID-19
TUESDAY, Sept. 1, 2020 (HealthDay News) — A Foster Farms chicken processing plant in Livingston, California, where eight workers died of COVID-19 and 392 tested positive, will be closed for a week of cleaning.
GM, Ford Finish Making 80,000 Ventilators
TUESDAY, Sept. 1, 2020 (HealthDay News) — General Motors and Ford have completed U.S. government contracts to make 80,000 medical breathing machines for the U.S. government to help treat COVID-19 patients.
SARS-CoV-2 Antibodies for 6 Percent of Frontline Health Care Personnel
TUESDAY, Sept. 1, 2020 (HealthDay News) — Six percent of health care personnel (HCP) caring for patients with COVID-19 have positive test results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, according to research published in the Aug. 31 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Workplace Climate Drives Nurses’ Perception of Burnout
TUESDAY, Sept. 1, 2020 (HealthDay News) — Workplace climate is the factor most associated with burnout in nurses, according to a study published Sept. 1 in the American Journal of Critical Care.
Copyright © 2020 ScoutNews, LLC. All rights reserved.